PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
WST vs. ALGN
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between WST and ALGN is 0.41, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


-0.50.00.51.00.4

Performance

WST vs. ALGN - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in West Pharmaceutical Services, Inc. (WST) and Align Technology, Inc. (ALGN). The values are adjusted to include any dividend payments, if applicable.

-15.00%-10.00%-5.00%0.00%5.00%10.00%JulyAugustSeptemberOctoberNovemberDecember
-0.30%
-12.45%
WST
ALGN

Key characteristics

Sharpe Ratio

WST:

-0.17

ALGN:

-0.65

Sortino Ratio

WST:

0.03

ALGN:

-0.77

Omega Ratio

WST:

1.00

ALGN:

0.91

Calmar Ratio

WST:

-0.16

ALGN:

-0.34

Martin Ratio

WST:

-0.34

ALGN:

-1.05

Ulcer Index

WST:

19.61%

ALGN:

23.13%

Daily Std Dev

WST:

38.79%

ALGN:

37.13%

Max Drawdown

WST:

-55.52%

ALGN:

-92.80%

Current Drawdown

WST:

-29.58%

ALGN:

-71.56%

Fundamentals

Market Cap

WST:

$24.21B

ALGN:

$17.08B

EPS

WST:

$6.75

ALGN:

$5.87

PE Ratio

WST:

49.52

ALGN:

38.98

PEG Ratio

WST:

6.24

ALGN:

1.35

Total Revenue (TTM)

WST:

$2.88B

ALGN:

$3.96B

Gross Profit (TTM)

WST:

$1.00B

ALGN:

$2.79B

EBITDA (TTM)

WST:

$743.90M

ALGN:

$811.39M

Returns By Period

In the year-to-date period, WST achieves a -6.18% return, which is significantly higher than ALGN's -24.24% return. Over the past 10 years, WST has outperformed ALGN with an annualized return of 20.43%, while ALGN has yielded a comparatively lower 13.90% annualized return.


WST

YTD

-6.18%

1M

4.10%

6M

-0.30%

1Y

-6.92%

5Y*

17.27%

10Y*

20.43%

ALGN

YTD

-24.24%

1M

-8.11%

6M

-12.45%

1Y

-23.65%

5Y*

-5.68%

10Y*

13.90%

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

WST vs. ALGN - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for West Pharmaceutical Services, Inc. (WST) and Align Technology, Inc. (ALGN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for WST, currently valued at -0.17, compared to the broader market-4.00-2.000.002.00-0.17-0.65
The chart of Sortino ratio for WST, currently valued at 0.03, compared to the broader market-4.00-2.000.002.004.000.03-0.77
The chart of Omega ratio for WST, currently valued at 1.00, compared to the broader market0.501.001.502.001.000.91
The chart of Calmar ratio for WST, currently valued at -0.16, compared to the broader market0.002.004.006.00-0.16-0.34
The chart of Martin ratio for WST, currently valued at -0.34, compared to the broader market-5.000.005.0010.0015.0020.0025.00-0.34-1.05
WST
ALGN

The current WST Sharpe Ratio is -0.17, which is higher than the ALGN Sharpe Ratio of -0.65. The chart below compares the historical Sharpe Ratios of WST and ALGN, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.00-0.500.000.50JulyAugustSeptemberOctoberNovemberDecember
-0.17
-0.65
WST
ALGN

Dividends

WST vs. ALGN - Dividend Comparison

WST's dividend yield for the trailing twelve months is around 0.25%, while ALGN has not paid dividends to shareholders.


TTM20232022202120202019201820172016201520142013
WST
West Pharmaceutical Services, Inc.
0.25%0.22%0.31%0.15%0.23%0.41%0.58%0.54%0.58%0.75%0.77%0.78%
ALGN
Align Technology, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Drawdowns

WST vs. ALGN - Drawdown Comparison

The maximum WST drawdown since its inception was -55.52%, smaller than the maximum ALGN drawdown of -92.80%. Use the drawdown chart below to compare losses from any high point for WST and ALGN. For additional features, visit the drawdowns tool.


-70.00%-60.00%-50.00%-40.00%-30.00%JulyAugustSeptemberOctoberNovemberDecember
-29.58%
-71.56%
WST
ALGN

Volatility

WST vs. ALGN - Volatility Comparison

The current volatility for West Pharmaceutical Services, Inc. (WST) is 6.26%, while Align Technology, Inc. (ALGN) has a volatility of 12.72%. This indicates that WST experiences smaller price fluctuations and is considered to be less risky than ALGN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


10.00%15.00%20.00%JulyAugustSeptemberOctoberNovemberDecember
6.26%
12.72%
WST
ALGN

Financials

WST vs. ALGN - Financials Comparison

This section allows you to compare key financial metrics between West Pharmaceutical Services, Inc. and Align Technology, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2024 PortfoliosLab